Duquesne Family Office’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-659,750
| Closed | -$3.77M | – | 73 |
|
|
2023
Q4 | $3.77M | Hold |
659,750
| – | – | 0.11% | 46 |
|
|
2023
Q3 | $3.04M | Hold |
659,750
| – | – | 0.11% | 37 |
|
|
2023
Q2 | $4.26M | Hold |
659,750
| – | – | 0.15% | 47 |
|
|
2023
Q1 | $4.98M | Hold |
659,750
| – | – | 0.22% | 40 |
|
|
2022
Q4 | $6.68M | Hold |
659,750
| – | – | 0.33% | 38 |
|
|
2022
Q3 | $6.53M | Hold |
659,750
| – | – | 0.37% | 42 |
|
|
2022
Q2 | $7.03M | Hold |
659,750
| – | – | 0.51% | 25 |
|
|
2022
Q1 | $6.43M | Hold |
659,750
| – | – | 0.28% | 34 |
|
|
2021
Q4 | $9.43M | Hold |
659,750
| – | – | 0.34% | 30 |
|
|
2021
Q3 | $13.2M | Buy |
+659,750
| New | +$13.2M | 0.43% | 34 |
|
|
2021
Q2 | – | Sell |
-659,750
| Closed | -$22.4M | – | 54 |
|
|
2021
Q1 | $22.4M | Hold |
659,750
| – | – | 0.49% | 43 |
|
|
2020
Q4 | $26.5M | Buy |
+659,750
| New | +$26.5M | 0.72% | 33 |
|